Multifocal spinal and extra-spinal Mycobacterium chelonae osteomyelitis in a renal transplant recipient

Transplant Infectious Disease

Volumn 9, Issue 1, 2007, Pages 62-65

  Korres, D S ^a   Papagelopoulos, P J ^a   Zahos, K A ^a   Kolia, M D ^a   Poulakou, G G ^a   Falagas, M E ^b,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

Author keywords

Corticosteroid therapy; Immunosuppression; Magnetic resonance imaging; Mycobacterium chelonae; Organ transplantation; Osteomyelitis; Spinal infections; Spondylodiscitis

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; AZATHIOPRINE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ADULT; ARTICLE; BONE BIOPSY; BONE DEFECT; BONE PLATE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GLOMERULONEPHRITIS; GRAFT RECIPIENT; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KYPHOSIS; LIVER TOXICITY; LONG TERM CARE; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; NEUROLOGICAL COMPLICATION; OSTEOMYELITIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SIDE EFFECT; SKIN DEFECT; SPINAL CORD COMPRESSION; SPINAL CORD DECOMPRESSION; SPINE; SPINE FUSION; SPONDYLITIS; SPONDYLOLISTHESIS; UNSPECIFIED SIDE EFFECT;

ANTI-INFECTIVE AGENTS; CERVICAL VERTEBRAE; CIPROFLOXACIN; CLARITHROMYCIN; DISCITIS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; KYPHOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; OSTEOMYELITIS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TUBERCULOSIS, SPINAL;

EID: 33846968819     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00178.x     Document Type: Article

References (15)

1. Sungkanuparph S, Sathapatayavongs B, Pracharktam R. Infections with rapidly growing mycobacteria: report of 20 cases. Int J Infect Dis 2003; 7: 198-205.
2. Suttner NJ, Adhami Z, Aspoas AR. Mycobacterium chelonae lumbar spinal infection. Br J Neurosurg 2001; 15: 265-269.
3. Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992; 166: 405-412.
4. Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR. Disseminated infections with rapidly growing mycobacteria. Clin Infect Dis 1993; 16: 463-471.
5. Brown-Elliott BA, Wallace RJ Jr, Blinkhorn R, Crist CJ, Mann LB. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin Infect Dis 2001; 33: 1433-1434.
6. Endzweig CH, Strauss E, Murphy F, Rao BK. A case of cutaneous Mycobacterium chelonae abscessus infection in a renal transplant patient. J Cutan Med Surg 2001; 5: 28-32.
7. Abramovitz JN, Batson RA, Yablon JS. Vertebral osteomyelitis: the surgical management of neurological complications. Spine 1986; 11: 418-420.
8. Oga M, Arizono T, Takasita M, Sugioka Y. Evaluation of the risk of instrumentation as a foreign body in the spinal tuberculosis: clinical and biological study. Spine 1993; 18: 1890-1894.
9. Yilmaz C, Selek HY, Gurkan I, Erdemli B, Korkusuz Z. Anterior instrumentation for the treatment of spinal tuberculosis. J Bone Joint Surg Am 1999; 81A: 1261-1267.
10. Jin D, Qu D, Chen J, Zhang H. One-stage anterior interbody autografting and instrumentation in primary surgical management of thoracolumbar spinal tuberculosis. Eur Spine J 2004; 13: 114-121.
11. Fernandez-Roblas R, Esteban J, Cabria F, Lopez JC, Jimenez MS, Soriano F. In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. Antimicrob Agents Chemother 2000; 44: 181-182.
12. Vemulapalli RK, Cantey JR, Steed LL, Knapp TL, Thielman NM. Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: case report and literature review. J Infect Dis 2001; 43: 163-168.
13. Wallace RJ Jr, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR- 936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 2002; 46: 3164-3167.
14. Wallace RJ Jr, Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW. Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother 2001; 45: 764-767.
15. Pruit TC, Hughes LO, Blasier RD, McCarthy RE, Glasier CM, Roloson GJ. Non-tuberculous mycobacterial vertebral osteomyelitis in a steroid depended adolescent. A case report. Spine 1993; 18: 2553-2555.